Results 251 to 260 of about 106,917 (289)
Strong, antioxidant, and biodegradable gelatin methacryloyl composite hydrogel for oxidative stress protection in Schwann cells. [PDF]
Han H +7 more
europepmc +1 more source
ABSTRACT X‐linked adrenoleukodystrophy (ALD) is a genetic disorder with neurological and endocrine manifestations, including myelopathy and hypergonadotropic hypogonadism. Many patients experience sexual dysfunction but the underlying cause has not been clarified.
Stephanie I. W. van de Stadt +4 more
wiley +1 more source
YAP and TAZ control peripheral myelination and the expression of laminin receptors in Schwann cells
Yannick Poitelon +16 more
openalex +2 more sources
Dock1 functions in Schwann cells to regulate development, maintenance, and repair. [PDF]
Doan RA, Monk KR.
europepmc +1 more source
Peripheral Neuropathy Expands the Neurological Phenotype in Glutaric Aciduria Type 1
ABSTRACT Glutaric aciduria type 1 (GA1) is a neurometabolic disorder characterized by striatal injury in infancy and extrastriatal central nervous system abnormalities, the latter depending on the biochemical subtype. Whether the peripheral nervous system (PNS) is also affected has not been systematically studied.
Fabian Preisner +8 more
wiley +1 more source
The effect of denervated muscle and Schwann cells on axon collateral sprouting
You-Gang Chen, Thomas M. Brushart
openalex +1 more source
GMPPB‐CDG Results in Lysosomal Dysfunction and Acid Alpha‐Glucosidase Deficiency
ABSTRACT GDP‐mannose pyrophosphorylase B (GMPPB) deficiency is a congenital disorder of glycosylation due to pathogenic variants of the GMPPB gene. GMPPB catalyzes GDP‐mannose synthesis, an early step in multiple glycosylation pathways, including N‐glycosylation, O‐mannosylation, C‐mannosylation, and glycosylphosphatidylinositol‐anchor formation.
Carla Damiano +20 more
wiley +1 more source
Schwann Cells in Neuromuscular Disorders: A Spotlight on Amyotrophic Lateral Sclerosis. [PDF]
Moss KR, Saxena S.
europepmc +1 more source

